AI Assistant
Blog
Pricing
Log In
Sign Up
Live vaccines and immunosuppressive monoclonal antibodies: weighing up the benefit–risk assessment for natalizumab
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
